Test side

TEST SIDE

Introducing BIOFAC Group

75 years experience in advancing bioactive ingredients
→ 5 factories across Denmark; all cGMP approved by the Danish Health and Medicines Authority
→ Sales office in Japan (Nagoya, est. 2015)
→ 140 employees in 2023
1950
VIGO ØSTERGAARD Slaughterhouse offal to produce Heparin + Plasma powder
1955 BIOFAC A/S was founded
Intrinsic factor + stabilized rumen extract
1984 BIOFAC A/S EJBY
Variety of products based on animal organs.

In 1984 BIOFAC A/S, Ejby was established in the modern dairy plant of Ejby Mejeri. In this plant, BIOFAC produces a variety of products based on animal glands. The plant is extremely flexible, which often enables us to customize the quality of our products to suit the exact needs of our individual clients. Among others products, the plant produces Hem Iron, Liver Hydrolysates, and Caviar Collagen. BIOFAC A/S, Ejby holds a cGMP Compliance of a Manufacturer by Danish Health and Medicines Authority.
1987 Orthana Kemisk Fabrik
Saliva, Pepsin, Peptones, Placenta Extracts + Chicken Collagens

In 1987 BIOFAC A/S took over Orthana Kemisk Fabrik, which was founded in 1934 by the Mørch family. Through the 50’s and 60’s the focus turned more and more towards specialising the production, concentrating on 3 major areas, Pepsins, Peptones, and Mucins. During the 80’s and 90’s innovative measures brought purified versions of mucin, resulting in the artificial saliva formulation, Saliva Orthana®, specially designed peptones, and high activity pepsins. Saliva Orthana® is now a registered Medical Device. These products along with a range of Placenta Extracts and Chicken Collagen are now the foundation of the Orthana product line. Orthana is located in Kastrup, Copenhagen, Denmark along with our administration premises. Orthana holds a cGMP Compliance of a Manufacturer by Danish Health and Medicines Authority.
1988 Danipharm A/S
Lactulose in bulk form.

In 1988, the BIOFAC A/S group of companies acquired a chemical factory in Northern Jutland, Denmark. A lot of new equipment and machinery was installed and in August 1989 Danipharm A/S started a production of Lactulose Concentrate. Today Danipharm A/S is a completely modern, effective and well-functioning production unit, inspected and approved by the US FDA, as well as by the Danish Health and Medicines Authority (holds a cGMP certificate). Danipharm A/S supplies Lactulose in bulk form.
1988 PharmaDan A/S
Manufacture finished, liquid pharmaceuticals

The superior modern production lines of PharmaDan A/S are situated in Østerbølle, Jutland, Denmark, and designated for filling and packing of liquid products. PharmaDan A/S is approved by the Danish Health Authority with both certificate of cGMP compliance of a Manufacturer and the Manufacturer’s Authorization. PharmaDan A/S offers filling and packing of Lactulose, Lactulose related products, and other liquid products on contract manufacturing basis.
2005 BIOFAC A/S Kastrup
Production of pharmaceutical enzymes, i.e. Thrombin, Bionuclease

In 2005, BIOFAC A/S decided to move the existing production facilities for Thrombin to a completely modernized building in Kastrup. Here BIOFAC A/S Kastrup was established producing the pharmaceutical enzymes Thrombin and Fibrinolysin (Bionuclease®). Both these completely new production lines are cGMP approved by the Danish Health and Medicines Authority.
2015 BIOFAC A/S Japan LtD
Subsidiary of Biofac Sales Office to expand business in Japan

Biofac Japan Ltd is a subsidiary of BIOFAC and our Sales office, established in Nagoya Japan in 2015 with a primary purpose to handle BIOFAC’s business in Japan. Regional presence and local expertise make us able to stay close to our expanding customer base in Japan. We see significant potential for our business in Japan, enhancing the business for existing products and developing new innovative products in close cooperation with our japanese customers. The operation of BIOFAC Japan is managed by Mr. Hisanobu Shimizu, who, together with his team, brings to the market full support within customer service, sales, technical expertise and application for a full range of BIOFAC products. To learn more about BIOFAC Japan and to find information about BIOFAC’s range of products in local language please visit www.biofac.co.jp.
2023 BIOFAC A/S Launching of Thyroid USP and FDA approval
Launching of Thyroid USP and FDA approval
Previous
Next
By continuing to browse the site, you accept our use of cookies